KASSANDRE BALOCCA: Open Payments
NPI 1205258027 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$120 in 7 payments from 4 companies in 2025. Trend: 2023 $290 · 2024 $321 · 2025 $120
Food & beverage: $120
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Amgen Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: VERQUVO, LEQVIO, REPATHA, Kerendia.
Industry payments across OK — which companies pay providers there.
